Testing effectiveness (Phase 2)Study completedNCT04563871
What this trial is testing
Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)
Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sehhoon Park 73